WO2007011698A3 - Humanized antibody conjugates and related methods, assays, reagents, and kits - Google Patents

Humanized antibody conjugates and related methods, assays, reagents, and kits Download PDF

Info

Publication number
WO2007011698A3
WO2007011698A3 PCT/US2006/027312 US2006027312W WO2007011698A3 WO 2007011698 A3 WO2007011698 A3 WO 2007011698A3 US 2006027312 W US2006027312 W US 2006027312W WO 2007011698 A3 WO2007011698 A3 WO 2007011698A3
Authority
WO
WIPO (PCT)
Prior art keywords
humanized antibody
kits
reagents
antibody conjugates
related methods
Prior art date
Application number
PCT/US2006/027312
Other languages
French (fr)
Other versions
WO2007011698A2 (en
Inventor
Linda-Marie Anderson-Mauser
Mary Margaret Foltz
Robert John Dwyer
Original Assignee
Bayer Healthcare Llc
Linda-Marie Anderson-Mauser
Mary Margaret Foltz
Robert John Dwyer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc, Linda-Marie Anderson-Mauser, Mary Margaret Foltz, Robert John Dwyer filed Critical Bayer Healthcare Llc
Priority to EP06787249A priority Critical patent/EP1922412A4/en
Publication of WO2007011698A2 publication Critical patent/WO2007011698A2/en
Publication of WO2007011698A3 publication Critical patent/WO2007011698A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides synthetically and recombinantly-derived humanized antibody conjugates and related methods, diagnostic assays, reagents, and kits. In one embodiment, the invention provides humanized antibody conjugates comprising a human immunoglobulin fragment which is bound by a cross-linking functional group to a non-human antibody fragment (e.g., a non-human monoclonal antibody fragment) comprising an antigen-binding amino acid sequence.
PCT/US2006/027312 2005-07-15 2006-07-14 Humanized antibody conjugates and related methods, assays, reagents, and kits WO2007011698A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06787249A EP1922412A4 (en) 2005-07-15 2006-07-14 Humanized antibody conjugates and related methods, assays, reagents, and kits

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69961805P 2005-07-15 2005-07-15
US60/699,618 2005-07-15
US70836105P 2005-08-31 2005-08-31
US60/708,361 2005-08-31

Publications (2)

Publication Number Publication Date
WO2007011698A2 WO2007011698A2 (en) 2007-01-25
WO2007011698A3 true WO2007011698A3 (en) 2007-06-28

Family

ID=37669378

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/027312 WO2007011698A2 (en) 2005-07-15 2006-07-14 Humanized antibody conjugates and related methods, assays, reagents, and kits

Country Status (2)

Country Link
EP (1) EP1922412A4 (en)
WO (1) WO2007011698A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858752B2 (en) 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
JP2010519916A (en) * 2007-03-06 2010-06-10 リボバックス バイオテクノロジーズ ソシエテ アノニム Antibodies specific for rubella virus
CN103383393B (en) * 2013-06-28 2015-11-25 英科隆生物技术（杭州）有限公司 A kind of quality-control product of alternative patient's positive blood
CN108445224A (en) * 2018-02-26 2018-08-24 王贤俊 A kind of cardic fatty acid binding protein antibody fragment compounded latex particle and preparation method thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929543A (en) * 1987-05-14 1990-05-29 Boehringer Mannheim Gmbh Process for the determination of an antibody in human body fluids
US5614367A (en) * 1989-01-10 1997-03-25 Boehringer Mannheim Gmbh Diagnostic test using chimeric antibodies
US6015662A (en) * 1996-01-23 2000-01-18 Abbott Laboratories Reagents for use as calibrators and controls
US6207815B1 (en) * 1988-10-19 2001-03-27 The Dow Chemical Company Family of high affinity, modified antibodies for cancer treatment
US6303755B1 (en) * 1996-07-11 2001-10-16 Medarex, Inc. Therapeutic multispecific compounds comprised of anti-FCA receptor antibodies
US6630292B2 (en) * 2000-04-25 2003-10-07 Fuji Photo Film B.V. Method for producing a silver halide photographic emulsion
US6849259B2 (en) * 2000-06-16 2005-02-01 Symphogen A/S Polyclonal antibody composition for treating allergy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681566A (en) * 1988-10-24 1997-10-28 3I Research Exploitation Limited Antibody conjugates with two or more covalently linked FC regions

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929543A (en) * 1987-05-14 1990-05-29 Boehringer Mannheim Gmbh Process for the determination of an antibody in human body fluids
US6207815B1 (en) * 1988-10-19 2001-03-27 The Dow Chemical Company Family of high affinity, modified antibodies for cancer treatment
US5614367A (en) * 1989-01-10 1997-03-25 Boehringer Mannheim Gmbh Diagnostic test using chimeric antibodies
US6015662A (en) * 1996-01-23 2000-01-18 Abbott Laboratories Reagents for use as calibrators and controls
US6303755B1 (en) * 1996-07-11 2001-10-16 Medarex, Inc. Therapeutic multispecific compounds comprised of anti-FCA receptor antibodies
US6630292B2 (en) * 2000-04-25 2003-10-07 Fuji Photo Film B.V. Method for producing a silver halide photographic emulsion
US6849259B2 (en) * 2000-06-16 2005-02-01 Symphogen A/S Polyclonal antibody composition for treating allergy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1922412A4 *

Also Published As

Publication number Publication date
WO2007011698A2 (en) 2007-01-25
EP1922412A4 (en) 2009-07-15
EP1922412A2 (en) 2008-05-21

Similar Documents

Publication Publication Date Title
HRP20191462T1 (en) Antibodies directed to her-3 and uses thereof
EA201100527A1 (en) BIOLOGICAL PRODUCTS
WO2006104978A3 (en) Antibodies against the tenascin major antigens
IN2012DN02535A (en)
WO2006061723A3 (en) Human monoclonal antibodies to influenza m2 protein and methods of making and using same
WO2006039258A3 (en) Human antibodies against parathyroid hormone
WO2008101177A3 (en) Ige antibodies to chimeric or humanized igg therapeutic monoclonal antibodies as a screening test for anaphylaxis
WO2006031653A3 (en) Humanized anti-5t4 antibodies and anti-5t4 antibody / calicheamicin conjugates
WO2006130458A3 (en) Antibodies directed to cd20 and uses thereof
EA201100231A1 (en) DIAGNOSTIC ANALYSIS BASED ON ANTIBODIES
WO2006113643A3 (en) High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies
WO2009010539A3 (en) Receptor for interleukin-6 (il-6) from macaca fascicularis
WO2006094192A3 (en) Humanized l243 antibodies
WO2005016111A3 (en) Antibodies directed to parathyroid hormone (PTH) and uses thereof
WO2006086208A3 (en) 5-fluoro-uracil immunoassay
UA94576C2 (en) Isolated antibody that binds to igf-1r, composition and methods relating to anti-igf-1 receptor antibodies
WO2007120693A3 (en) Targeted binding agents directed to upar and uses thereof
WO2006047670A3 (en) Methods for assessing antibodies to neurodegenerative disease-associated antigens
IL212056A0 (en) Monoclonal antibodies and methods for their use in the detection of cervical disease
MX2008002161A (en) Chimeric antibodies with new world primate regions.
EP3300739A3 (en) Antibodies and related molecules that bind to 161p2f10b proteins
WO2008143697A3 (en) Antibody with protein a selectivity
WO2008140570A3 (en) Antibody with protein a selectivity
WO2007001895A3 (en) Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase
WO2011064257A3 (en) Monospecific polypeptide reagents

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006787249

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE